Get your fresh news on health and wellness in New York

Provided by AGP

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on April 7, 2026

The Unquiet Mind Offers a Compassionate Literary Guide for Those Living With Anxiety and Emotional Struggle
As U.S. Healthcare Spending Surpasses $4 Trillion, a Former Air Force Colonel Introduces ‘Holistic Systems Health‘ Model
Kinetic Wins Multiple Honors, Celebrating the People Behind Innovation in Workers’ Compensation Insurance
Sigma Biotech Consulting Group Launches to Accelerate Biotech and Medical Device Innovation
Becker Transactions Presents Global Patent Portfolio for Next-Generation Dual-Ionization Mass Spectrometry
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Voting Rights and Shares Capital of the Company
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
As Easter Travel Triggers Bed Bug Infestation Warning Fantastic Pest Control Rolls Out Faster, More Efficient, Low-pesticide Heat Treatment
BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Amneal to Report First Quarter 2026 Results on May 1, 2026
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
MHM Invests $237.5 Million to Create a Healthier Future Across South Texas
Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications
Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients' Side Effects Risk for GlucoZen

Share us

on your social networks:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.